A Four-week Clinical Trial Investigating Efficacy and Safety of Cannabidiol As a Treatment for Acutely Ill Schizophrenic Patients
Clinical trial NCT02088060 · TERMINATED
Trial details
- NCT number
- NCT02088060
- Sponsor
- Central Institute of Mental Health, Mannheim
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-08
- Primary completion
- 2024-09-16
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.